ASP Isotopes (NASDAQ:ASPI) Sets New 1-Year Low – What’s Next?

ASP Isotopes Inc. (NASDAQ:ASPI) hit a new 52-week low during mid-day trading on Friday . The company traded as low as $3.87 and last traded at $3.94, with a volume of 8163811 shares traded. The stock had previously closed at $4.58.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Canaccord Genuity Group restated a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a report on Tuesday, April 14th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $13.00.

ASP Isotopes Stock Performance

The stock has a 50 day simple moving average of $6.17 and a 200 day simple moving average of $5.83. The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69. The company has a market cap of $496.05 million, a price-to-earnings ratio of -1.89 and a beta of 3.51.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.06. The business had revenue of $8.36 million during the quarter, compared to analyst estimates of $3.68 million. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.

Insider Buying and Selling

In other news, CFO Heather Kiessling sold 23,124 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $6.28, for a total transaction of $145,218.72. Following the transaction, the chief financial officer directly owned 1,526,252 shares of the company’s stock, valued at approximately $9,584,862.56. The trade was a 1.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Michael Gorley sold 30,000 shares of the company’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $6.27, for a total transaction of $188,100.00. Following the completion of the transaction, the director owned 87,908 shares of the company’s stock, valued at $551,183.16. This trade represents a 25.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 279,079 shares of company stock valued at $2,049,208 over the last three months. Company insiders own 14.40% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

A number of large investors have recently added to or reduced their stakes in the company. State of Wyoming purchased a new stake in ASP Isotopes during the 1st quarter worth $29,000. Quantbot Technologies LP purchased a new position in ASP Isotopes in the 3rd quarter valued at about $34,000. BNP Paribas Financial Markets boosted its position in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after buying an additional 2,548 shares during the last quarter. Stephens Inc. AR acquired a new stake in shares of ASP Isotopes during the first quarter valued at about $44,000. Finally, Broadhurst Jeffrey B purchased a new stake in shares of ASP Isotopes during the first quarter worth about $44,000. 16.80% of the stock is owned by institutional investors and hedge funds.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.